Angpt2/Tie2 autostimulatory loop controls tumorigenesis

Area of Science:

• Endocrinology
• Oncology
• Molecular Biology

Background:

• Invasive nonfunctioning pituitary neuroendocrine tumors (NF-PitNETs) are challenging to treat, often relapsing and causing significant comorbidities.
• Current therapies for NF-PitNETs are frequently ineffective, necessitating the identification of novel therapeutic targets.

Purpose of the Study:

• To investigate the role of the angiopoietin-2 (ANGPT2)/TIE2 axis in the growth and progression of NF-PitNETs.
• To evaluate the therapeutic potential of targeting the ANGPT2/TIE2 signaling pathway in NF-PitNETs.

Main Methods:

• Utilized GH3 PitNET cell line, primary human NF-PitNET cells, zebrafish and mouse xenografts, and MENX rats (an autochthonous NF-PitNET model).
• Assessed ANGPT2/TIE2 expression and function in tumor cells, including TIE2 receptor activity and downstream signaling.
• Investigated the effects of TIE2 gene deletion and pharmacological inhibition of the ANGPT2/TIE2 axis on PitNET growth in vitro and in vivo.

Main Results:

• PitNET cells express functional TIE2 receptors and secrete bioactive ANGPT2, promoting tumor cell growth via autocrine and paracrine mechanisms.
• ANGPT2 stimulation of TIE2 in PitNET cells activates proliferation signaling pathways.
• TIE2 gene deletion and pharmacological inhibition of the ANGPT2/TIE2 axis significantly reduced PitNET growth in various preclinical models.

Conclusions:

• The ANGPT2/TIE2 axis is a critical driver of NF-PitNET progression and represents a viable therapeutic target.
• Targeting the ANGPT2/TIE2 pathway may offer a new treatment strategy for NF-PitNETs and potentially other tumors utilizing this axis.
• Tumor cells can hijack angiogenic signaling pathways, like ANGPT2/TIE2, for their own growth, expanding understanding of tumor microenvironment interactions.